Skip to main content
OpenTrials

Clinical trial condition

Metabolism, Inborn Errors

Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

2,499 public trials 456 recruiting studies
Refine in advanced search Browse all conditions

Metabolism, Inborn Errors trial results

Completed

Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)

NCT03500094

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Clinical Study Site Tampa, Florida, United States
  • Clinical Study Site Atlanta, Georgia, United States
  • Clinical Study Site Minneapolis, Minnesota, United States
  • Clinical Study Site Columbia, Missouri, United States
View Trial Details
Completed

A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients

NCT03423186

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Childrens's Hospital and Research Center Oakland, California, United States
  • University of North Carolina Hospitals Chapel Hill, North Carolina, United States
  • University Medical Center Hamburg-Eppendorf Hamburg, Germany
  • Gazi University Hospital Ankara, Turkey (Türkiye)
View Trial Details
Completed

Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2

NCT04470713

Conditions
AB Variant Gangliosidosis GM2, Brain Diseases, Brain Diseases, Metabolic, +24 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
  • Lysosomal and Rare Disorders Research and Treatment Center Fairfax, Virginia, United States
  • UCL Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 17 locations
View Trial Details
Completed

Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients

NCT04040816

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Anaheim Clinical Trials (ACT) Anaheim, California, United States
  • Miami Research Associates South Miami, Florida, United States
  • Advanced Clinical Research Meridian, Idaho, United States
View Trial Details
Completed

A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

NCT00000970

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Washington U CRS St Louis, Missouri, United States
  • Memorial Sloan-Kettering Cancer Ctr. New York, United States
View Trial Details
Completed

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

NCT00000768

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Washington U CRS St Louis, Missouri, United States
  • NY Univ. HIV/AIDS CRS New York, United States
View Trial Details

Related conditions